9‐cis retinoic acid accelerates calcitriol‐induced osteocalcin production and promotes degradation of both vitamin D receptor and retinoid X receptor in human osteoblastic cells
- 1 July 2003
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 89 (6) , 1164-1176
- https://doi.org/10.1002/jcb.10572
Abstract
Vitamin D receptor (VDR) and retinoid X receptor (RXR) heterodimerize to mediate the genomic actions of 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3, calcitriol), the biologically active form of vitamin D3. In this study, we show that 9-cis retinoic acid (9-cisRA), the ligand for RXR, accelerates calcitriol-induced expression of osteocalcin gene, the marker for mature osteoblasts. Calcitriol and its synthetic analog KH1060 (1 nM) induced osteocalcin secretion after a 96-h incubation period as detected by radioimmunoassay. When these compounds were used together with 9-cisRA, osteocalcin protein secretion was, however, detected already after 72 and 48 h, respectively. Detection of osteocalcin mRNA with quantitative PCR revealed elevated mRNA levels already after a 4-h treatment of the cells with calcitriol, KH1060, or 9-cisRA compared with untreated cells. In combination treatments, 9-cisRA rapidly stimulated osteocalcin mRNA synthesis induced by the different vitamin D3 compounds. In MG-63 cells treated with calcitriol or KH1060, the stimulation was maximal after the first 4 h and diminished thereafter. In fact, after the 48-h incubation 9-cisRA reduced osteocalcin mRNA levels in KH1060-treated cells, the amount of mRNA being only 44% of the levels obtained with KH1060 alone. The reduction was accompanied by an increased degradation rate of both VDR and RXRβ in the presence of 9-cisRA. Furthermore, 9-cisRA increased the formation of RXRβ–VDR–VDRE complex on the osteocalcin gene VDRE. These results suggest that 9-cisRA accelerates calcitriol-induced osteocalcin production in human osteoblastic cells through increased formation of transcriptionally active chromatin complexes and, subsequently, promotes degradation of the heterodimeric complex of VDR and RXR.Keywords
Funding Information
- the academy of finland (30566)
- Technology Development Centre, Finland (40949/98)
This publication has 37 references indexed in Scilit:
- Functional Evidence for Retinoid X Receptor (RXR) as a Nonsilent Partner in the Thyroid Hormone Receptor/RXR HeterodimerMolecular and Cellular Biology, 2002
- Dimerization with Retinoid X Receptors Promotes Nuclear Localization and Subnuclear Targeting of Vitamin D ReceptorsJournal of Biological Chemistry, 2000
- Dimerization with Retinoid X Receptors and Phosphorylation Modulate the Retinoic Acid-induced Degradation of Retinoic Acid Receptors α and γ through the Ubiquitin-Proteasome PathwayPublished by Elsevier ,2000
- Differential Regulation of the Carbonic Anhydrase II Gene Expression by Hormonal Nuclear Receptors in Monocytic Cells: Identification of the Retinoic Acid Response ElementBiochemical and Biophysical Research Communications, 2000
- Induction of Androgen Receptor by 1 ,25-Dihydroxyvitamin D3 and 9-cis Retinoic Acid in LNCaP Human Prostate Cancer CellsEndocrinology, 1999
- Heterodimer Formation by Retinoid X Receptor: Regulation by Ligands and by the Receptor's Self-Association PropertiesBiochemistry, 1998
- The RXR heterodimers and orphan receptorsPublished by Elsevier ,1995
- Role of Ligand in Retinoid Signaling. 9-cis-Retinoic Acid Modulates the Oligomeric State of the Retinoid X ReceptorBiochemistry, 1995
- Functional Interference Between AP‐1 and the Vitamin D Receptor on Osteocalcin Gene Expression in Human Osteosarcoma CellsEuropean Journal of Biochemistry, 1994
- Homodimer formation of retinoid X receptor induced by 9-cis retinoic acidNature, 1992